CRISPR THERAPEUTICS AG (CRSP) Shareholders’ equity 2016–2025
CRISPR THERAPEUTICS AG (CRSP) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.9BFY2025 · since FY2016: $232.8M → $1.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9B | -0.5% |
| FY2024 | $1.9B | +2.6% |
| FY2023 | $1.9B | +0.4% |
| FY2022 | $1.9B | -21.8% |
| FY2021 | $2.4B | +44.2% |
| FY2020 | $1.7B | +77.2% |
| FY2019 | $939.4M | +139.5% |
| FY2018 | $392.2M | +108.8% |
| FY2017 | $187.8M | -19.3% |
| FY2016 | $232.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice